Search

Thyroid ultrasound elastography: does nodule stiffness predict malignancy?

Approximately 50% of the general population has a thyroid nodule while 5-15% of these are malignant [1]. A major challenge, therefore, is how to detect the malignant nodules for appropriate, timely treatment and avoid unnecessary, costly investigations for the remainder....

Robotic head and neck surgery: current state of the art and future innovations

Technology and innovation has provided modern head and neck surgeons with successive generations of robotic surgical systems, fibre-optic lasers, and novel tools which have ushered in a new era of minimally invasive surgery for tumours of the pharynx and larynx....

Adult hearing screening: consideration for a holistic model

Background Adult-onset hearing impairment is a highly prevalent and undertreated chronic problem that poses a significant burden of disease worldwide [1]. It is usually gradual and diagnosed and managed approximately 10 years after adults have first experienced hearing difficulties [2]....

Integrating technology into audiological rehabilitation programmes

In the future, the rehabilitation of adults with hearing loss is likely to involve modern information technology. Using the Internet in the audiological rehabilitation process might be a cost-effective way to include additional rehabilitation components by guiding hearing aid users...

Audiovestibular findings in children with enlarged vestibular aqueduct

Enlarged vestibular aqueduct is reported to affect up to 15% of the paediatric population with sensorineural hearing loss. Devin McCaslin and Bridget Smith provide an up-to-date overview of the mechanisms and clinical symptoms underlying the condition and share some of...

What’s in a name?

Kate Granger is a doctor and the founder of the #hellomynameis campaign; she is also a cancer patient. In this article she explains why she started the campaign, and why patient-centred care starts with an introduction. Chris and me the...

The changing spectrum of cancer of the oropharynx: dilemmas and future directions

The association of HPV in oropharyngeal cancer has identified a ‘new disease’, with its unique biologic behaviour, and challenges for clinicians in selecting therapeutic combinations offering maximum efficacy and minimum morbidity or long-term sequela currently under study in clinical trials....

Systemic agents in thyroid cancer

For those patients who have disseminated or unresectable thyroid cancer, Dr Arabella Hunt and Dr Kate Newbold review systemic treatments, their differences, toxicities and outcomes. Thyroid cancer is the most common endocrine malignancy. It is subdivided into differentiated (papillary, follicular...

Anxiety and acronyms – musings of an otolaryngologist

Personal protective equipment (PPE) has been a focus of attention and concern for healthcare workers around the globe during the COVID-19 pandemic. Neil Tolley discusses some of the issues. I write this article in mid-May when, were it not for...

OBITUARY: Nobuhiko Isshiki (1930–2022)

Ushering in a new era, the pioneer of laryngeal framework surgery remains an inspiration to this day. Prof Nobuhiko Isshiki in 2016 (courtesy: Mr Yakubu Karagama). The laryngological world has lost a great man. Professor Nobuhiko Isshiki passed away in...

IFOS 2021: imagining inspirational continuing professional development

If you expect a virtual presentation to be the same as an in-person presentation, just without the live person in front of you, then you have no imagination. Irrespective of the challenges facing us currently with meeting in person during...